Search research articles
Contact Us
Filters
Showing results (11-20 of 79) with videos related to
Page
of 8
Sort By:
BMC Nephrology
|
April 24, 2021
Practice variation in the treatment of patients with renal hyperparathyroidism: a survey-based study in the Netherlands
Jaimie L H Zhang, Natasha M Appelman-Dijkstra, Edouard L Fu, et al.
BMJ (Clinical Research Ed.)
|
June 26, 2024
SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study
Edouard L Fu, Deborah J Wexler, Sara J Cromer, et al.
Clinical Kidney Journal
|
July 5, 2021
Pharmacoepidemiology for nephrologists (part 1): concept, applications and considerations for study design
Marco Trevisan, Edouard L Fu, Yang Xu, et al.
Clinical Kidney Journal
|
December 17, 2024
Impact of arteriovenous fistula formation on trajectory of kidney function decline: a target trial emulation
Luis Loureiro Harrison, Edouard L Fu, Peter C Thomson, et al.
Circulation
|
February 24, 2026
Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation
Yang Xu, Tao Huang, Yue Zhang, et al.
Journal of Nephrology
|
December 2, 2022
Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project
Jim Alkas, Alessandro Bosi, Arvid Sjölander, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 14, 2023
Long-term Visit-to-Visit Variability in Hemoglobin A<sub>1c</sub> and Kidney-Related Outcomes in Persons With Diabetes
Yang Xu, Shujie Dong, Edouard L Fu, et al.
American Heart Journal
|
October 5, 2021
Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes
Yang Xu, Edouard L Fu, Marco Trevisan, et al.
Clinical Kidney Journal
|
November 2, 2023
The long-term benefits of early intensive therapy in chronic diseases-the legacy effect
Carmine Zoccali, Francesca Mallamaci, Giovanni Tripepi, et al.
American Heart Journal
|
August 6, 2019
High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post-myocardial infarction patients
Edouard L Fu, Mikael Andersson Franko, Achim Obergfell, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 79) with videos related to
Sort By:
Page
of 8
BMC Nephrology
|
April 24, 2021
Practice variation in the treatment of patients with renal hyperparathyroidism: a survey-based study in the Netherlands
Jaimie L H Zhang, Natasha M Appelman-Dijkstra, Edouard L Fu, et al.
BMJ (Clinical Research Ed.)
|
June 26, 2024
SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study
Edouard L Fu, Deborah J Wexler, Sara J Cromer, et al.
Clinical Kidney Journal
|
July 5, 2021
Pharmacoepidemiology for nephrologists (part 1): concept, applications and considerations for study design
Marco Trevisan, Edouard L Fu, Yang Xu, et al.
Clinical Kidney Journal
|
December 17, 2024
Impact of arteriovenous fistula formation on trajectory of kidney function decline: a target trial emulation
Luis Loureiro Harrison, Edouard L Fu, Peter C Thomson, et al.
Circulation
|
February 24, 2026
Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation
Yang Xu, Tao Huang, Yue Zhang, et al.
Journal of Nephrology
|
December 2, 2022
Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project
Jim Alkas, Alessandro Bosi, Arvid Sjölander, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 14, 2023
Long-term Visit-to-Visit Variability in Hemoglobin A<sub>1c</sub> and Kidney-Related Outcomes in Persons With Diabetes
Yang Xu, Shujie Dong, Edouard L Fu, et al.
American Heart Journal
|
October 5, 2021
Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes
Yang Xu, Edouard L Fu, Marco Trevisan, et al.
Clinical Kidney Journal
|
November 2, 2023
The long-term benefits of early intensive therapy in chronic diseases-the legacy effect
Carmine Zoccali, Francesca Mallamaci, Giovanni Tripepi, et al.
American Heart Journal
|
August 6, 2019
High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post-myocardial infarction patients
Edouard L Fu, Mikael Andersson Franko, Achim Obergfell, et al.
Page
of 8